| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
ProStat is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
YourPath is a healthcare provider that offers medication-assisted treatment and comprehensive assessments for individuals affected by substance use disorders.
IN Compass Health is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2019, Wellvana is a company designed to support independent physicians and help them thrive in their transition to value-based care. With a mission of creating a national footprint of high performing, locally narrow networks, Wellvana aims to deliver high quality and highly efficient healthcare services while contracting on behalf of and migrating physicians towards risk-based reimbursement methodologies. Wellvana provides the resources, experience, and leadership to allow physicians to practice effectively, achieve work life balance, and benefit from risk-based revenue models, while respecting cultural, regional, and individual practice uniqueness.